- “The calamities of this dreadful time” Sarah Skwire, Law & Liberty
- Collapse patchworks: a theory Chris Shaw, Libertarian Ideal
- Apocalypse never Jeremy Carl, Claremont Review of Books
- The Big Questions in economics (podcast) EconTalk
Year: 2020
The short-sightedness of big C Conservatism
As we celebrate the approval of the Oxford-AstraZeneca Covid-19 vaccine, it is hard to imagine that anyone might take offense at the existence of an inexpensive, transportable solution to the pandemic. Yet this is exactly what I have encountered. A friend who is an arch-Conservative (note the capital C) responded with hostility during a discussion on differences between the Oxford and Pfizer vaccines. The issue was that my friend couldn’t accept the scientific evidence that the Oxford vaccine is superior to the Pfizer one. He fixated on the fifteen-billion-dollar subsidy Pfizer received from the US government to create their vaccine. For the Conservative, it was as if to admit the difference between the vaccines was unpatriotic since one was bought by the US taxpayer. His objections were not based on scientific evidence or ideology but upon identity and background.
During the discussion, my Conservative friend brought up the Oxford team’s continuous publication of their data as if that action somehow lessened their research’s impact or validity. The final paragraph on the Oxford research team’s webpage says:
This is just one of hundreds of vaccine development projects around the world; several successful vaccines offer the best possible results for humanity. Lessons learned from our work on this project are being shared with teams around the world to ensure the best chances of success.
The implication was “well, they’re just wacko do-gooders! They’re not going to make a profit acting like that!” The idea being that legitimate scientific research bodies behave like Scrooge McDuck with their knowledge. On a side note, this type of “Conservative” mentality has greatly damaged public perception of capitalism, a topic I’ll return to at a later point.
Members of the Oxford vaccine team are assumed to be in the running for the Nobel Prize, and for this, odds of winning are proportionate to the speed with which the broader scientific community can check findings. The Conservative could not overcome a mental block over the fifteen billion dollars. The difference is one of vision. To put it bluntly, Oxford is aware as an institution that it has existed for almost nine hundred years before the creation of Pfizer and that it will probably exist nine hundred years after Pfizer is no longer. Oxford wants the Nobel Prize; the long-term benefits – investment, grants, funding awards, etc. – far outweigh any one-time payout. As to the long-term outlook required for Nobel Prize pursuit, the willingness to pass up one benefit in favor of a multitude of others, it is alien to those whose focus is short-sighted, who are enticed by single-time subsidies or quick profits.
The conversation represented a problem which caused F.A. Hayek to write in “Why I am not a Conservative,”
In general, it can probably be said that the conservative does not object to coercion or arbitrary power so long as it is used for what he regards as the right purposes. He believes that if government is in the hands of decent men, it ought not to be too much restricted by rigid rules. Since he is essentially opportunist and lacks principles, his main hope must be that the wise and the good will rule—not merely by example, as we all must wish, but by authority given to them and enforced by them. Like the socialist, he is less concerned with the problem of how the powers of government should be limited than with that of who wields them; and, like the socialist, he regards himself as entitled to force the value he holds on other people.
In the case of the vaccine, the Conservative I spoke with had the idea that since the government sponsored Pfizer’s version, Americans ought to accept placidly the Pfizer vaccine as their lot in life. Consequently, coercive policies, for instance refusing the AstraZeneca vaccine FDA approval (something which hasn’t occurred – yet), are acceptable. Behind this facile, even lazy, view lies an incomprehension when confronted with behaviors and mindsets calibrated for large scale enterprises. Actions taken to achieve long-term building – in this instance the possibility of winning a Nobel Prize – are branded as suspicious, underhanded. At an even deeper level lies a resentment of AstraZeneca’s partner: Oxford with all of its associations.
Rather than being a malaise of big C “Conservatism,” the response, detailed in this anecdote, to a comparison between the vaccines conforms to Conservative ideas. Narrowness of mind and small scope of vision are prized. As Hayek pointed out in 1960, these traits lead to a socio-cultural and intellectual poverty which is as poisonous as the material and moral poverty of outright socialism. My own recent conclusion is that the poverty of big C “Conservatism” might be even worse than that of socialism because mental and socio-cultural poverty can create circumstances leading to a longer, more subtle slide into material poverty while accompanied by a growing resentment as conformity still leads to failure. When class and ideological dynamics invade matters such that scientific evidence is interpreted through political identities, we face a grave threat to liberty.
Nightcap
- 10 best history books of the decade RealClearHistory
- Learning from the past Helen Dale, Critic
- Against space exploration Kenneth Roy, Centauri Dreams
- …Happy new year!
Nightcap
- The weirdest people in the world James Crabtree, Financial Times
- Finding Mrs Dalloway Jenny Ofill, New Yorker
- Trapped by Thucydides? John Sullivan, War on the Rocks
- The emergence of globalism Or Rosenboim, In The Long Run
Nightcap
- American workers do not need unions Richard Epstein, Law & Liberty
- Subverting individualism David Henderson, EconLog
- A classic on caste in South Asia BR Ambedkar, Pragati
- Coronavirus and the seizing of property Ethan Blevins, NOL
Nightcap
- Hayek and Cassel on the Great Depression David Glasner, Uneasy Money
- Giving Trump the OJ treatment Thomas Knapp, WLGC
- Liberalism in Brazil Lucas Berlanza, Econ Journal Watch
- Brazil will not become Venezuela Bruno Rosi, NOL
Nightcap
- Albert Camus and imperial nostalgia Oliver Gloag (interview), Jacobin
- The true meaning of Christmas is a cozy American worldview Paul Musgrave, Foreign Policy
- The Christmas truce of 1914 Joseph Eanett, War on the Rocks
- Is cord-cutting still worth it? Stephen Silver, 19FortyFive
Nightcap
- Merry Christmas!
Nightcap
- Informative piece on EU-UK trade deal
- Who will save the world? Ryan Davis, 200-Proof Liberals
- Is this how fascism will come to America? Scott Sumner, Money Illusion
- A middle aged Christmas Ross Douthat, NY Times
Nightcap
- The antichrist: a biography Nicola Barker, Spectator
- A lunar pandemic Dagomar Degroot, Aeon
A touch of optimism
I remember when Obamacare was first being debated. The political right had so many strong arguments to make and they abjectly refused. Instead, Obama was declared a secret Muslim whose secret plan is to turn the frogs gay.
Here we are with that political tribe having ascended to the White House and now the political Left has so many strong arguments to make. And they’re refusing. Instead, the federal government needs to be made more powerful for the next time a Trump gets elected.
2020 has not been kind to my view of humanity. So I’m listening to The Rational Optimist (finally). And I’ve got to say, it’s just what the doctor ordered. Life is pretty good on balance, even with the bad stuff.
Nightcap
- On that radio signal from Proxima Centauri Paul Gilster, Centauri Dreams
- Wow! signal Wikipedia
- How far aggressive aliens? (Part 2) Robin Hanson, Overcoming Bias
- Legal immigration into the United States Jacques Delacroix, NOL
Nightcap
- It would take at least 6,300 years to reach the closest star to our sun MIT Review
- How far aggressive aliens? Robin Hanson, Overcoming Bias
- America’s long (and beautiful) anti-socialist history Matthew Wills, JStor Daily
- Big business got bigger in America during the pandemic George Dance, Political Animal
Nightcap
- Pfizer-Biontech: Firstcomers and latecomers Irfan Khawaja, Policy of Truth
- Alienation and double-think Chris Dillow, Stumbling & Mumbling
- It’s not just housing… Scott Sumner, EconLog
- Winters in medieval Europe Lucie Laumonier, Medievalists
Disruption arises from Antifragility
One of my favorite classics about why big businesses can’t always innovate is Clayton Christiansen’s The Innovator’s Dilemma. It is one of the most misunderstood business books, since its central concept–disruption–has been misquoted, and then popularized. Take the recent post on Investopedia that says in the second sentence that “Disruptive technology sweeps away the systems or habits it replaces because it has attributes that are recognizably superior.” This is the ‘hype’ definition used by non-innovators.
I think part of the misconception comes from thinking of disruption as major, public, technological marvels that are recognizable for their complexity or for even creating entire new industries. Disruptive innovations tend instead to be marginal, demonstrably simpler, worse on conventional scales, and start out by slowly taking over adjacent, small markets.
It recently hit me that you can identify disruption via Nassim Nicholas Taleb’s simple heuristics of recognizing when industry players are fragile. Taleb is my favorite modern philosopher, because he actually brought a new, universally applicable concept to the table, that puts into words what people have been practicing implicitly–but without a term to use. Anti-fragility is the inverse of fragile and actually helps you understand it better. Anti-fragile does not mean ‘resists breaking,’ which is more like ‘robust;’ instead, it means gains from chaos. Ford Pintos are fragile, Nokia phones are robust, but mechanical things are almost never anti-fragile. Bacteria species are anti-fragile to anti-biotics, as trying to kill them makes them stronger. Anti-fragile things are usually organic, and usually made up of fragile things–the death of one bacterium makes the species more resistant.
Taleb has a simple heuristic for finding anti-fragility. I recommend you read his book to get the full picture, but the secret to this concept is a simple thought experiment. Take any concept (or thing), and identify how it works (or fails to work). Now ask, if you subject it to chaos–by that, I mean, if you try to break it–and slowly escalate how hard you try, what happens?
- If it gets disproportionately harmed, it is fragile. E.g., traffic: as you add cars, time-to-destination gets worse slowly at first, then all of the sudden increases rapidly, and if you do it enough, cars literally stop.
- If it gets proportionately harmed or there is no effect, it is robust. Examples are easy, since most functional mechanical and electric systems are either fragile (such as Ford Pintos) or robust (Honda engines, Nokia phones, the Great Pyramids).
- If it gets better, it is anti-fragile. Examples are harder here, since it is easier to destroy than build (and anti-fragility usually occurs based on fragile elements, which gets confusing); bacterial resistance to anti-biotics (or really, the function of evolution itself) is a great one.
The only real way to get anti-fragility outside of evolution is through optionality. Debt (obligation without a choice) is fragile to any extraneous shock, so a ‘free option’–choice without obligation, the opposite, is pure anti-fragility. Not just literal ‘options’ in the market; anti-fragile takes a different form in every case, and though the face is different, the structure is the same. OK, get it? Maybe you do. I recommend coming up with your own example–if you are just free riding on mine, you don’t get it.
Anyway, back to Christiansen. Taleb likes theorizing and leaves example-finding to you, while Christiansen scrupulously documented what happened to hundreds of companies and his concepts arose from his data; think about it like Christiansen is Darwin, carefully measuring beaks, and recognizing natural selection, where Taleb is Wallace, theorizing from his experience and the underlying math of reality. Except in this case, Taleb is not just talking about natural selection, he is also showing how mutation works, and giving a theory of evolution that is not restricted to just biology.
I realized that you can actually figure out whether an innovation is disruptive using this heuristic. It takes some care, because people often look at the technology and ask if it is anti-fragile–which is a mistake. Technologies are inorganic, so usually robust or fragile. Industries are organic, strategies are organic, companies are organic. Many new strategies build on companies’ competencies or existing customer bases, and though they may meet the ‘hype’ definition above, they give upside to incumbents, and are thus not fragilizing. Disruption happens when a company has an exposure to a strategy that it has little to gain from, but that could cannibalize its market if it grows, as anti-fragile things are wont to do.
The questions is: is a given incumbent company fragile with respect to a given strategy? Let’s start with some examples–first Christiansen’s, then my own:
- Were 3″ drive makers fragile with respect to using smaller drives in cars?
- In my favorite Christiansen anecdote, a 3″ drive-making-CEO, whose company designed a smaller 1.8″ drive but couldn’t sell it to their PC or mainframe customers, complained that he did exactly what Christiansen said, and built smaller drives, and there was no market. Meanwhile, startups were selling 1.8″ drives like crazy–to car companies, for onboard computers.
- Christiansen notes that this was a tiny market, which would be an 0.01% change on a big-company income statement, and a low-profit one at that. So, since these companies were big, they were fragile to low-margin, low-volume, fast-growing submarkets. Meanwhile, startups were unbelievably excited about selling small drives at a loss, just so that Honda would buy from them.
- So, 3″ drive makers had everything to lose (the general drive market) and a blip to gain, where startups had everything to gain and nothing to lose. Note that disruptive technologies are not those that are hard to invent or that immediately revolutionize the industry. Big companies (as Christiansen proved) are actually better at big changes and at invention. They are worse at recognizing value of small changes and jumps between industries.
- Were book retailers fragile with respect to online book sales?
- Yes, Amazon is my Christiansen follow-on. Jeff Bezos, as documented in The Everything Store, gets disruption: he invented the ‘two-pizza meeting’, so he ‘gets’ smallness; he intentionally isolates his innovation teams, so he ‘gets’ the excitement of tiny gains and allows cannibalism; he started in a proof-of-concept, narrow, feasible discipline (books) with the knowledge that it would grow into the Everything Store if successful, so he ‘gets’ going from simple beginnings to large-scale, well, disruption.
- The Everything Store reads like a manual on how to be disrupted. Barnes & Noble first said “We can do that whenever we want.” Then when Bezos got some traction, B&N said “We can try this out but we need to figure out how to do it using our existing infrastructure.” Then when Bezos started eating their lunch, B&N said “We need to get into online book sales,” but sold the way they did in stores, by telling customers what they want, not by using Bezos’ anti-fragile review system. Then B&N said “We need to start doing whatever Bezos does, and beat him by out-spending,” by which time he was past that and selling CDs and then (eventually) everything.
- Book sellers were fragile because they had existing assets that had running costs; they were catering to customers with not just a book, but with an experience; they were in the business of selecting books for customers, not using customers for recommendations; they treasured partnerships with publishers rather than thinking of how to eliminate them.
- Now, some rapid-fire. Think carefully, since it is easy to fall into the trap of thinking industry titans were stupid, not fragile, and it is easy to have false positives unless you use Taleb’s heuristic.
- Car companies were fragile to electric sports cars, and Elon Musk was anti-fragile. Sure, he was up-market, which doesn’t follow Christiansen’s down-market paradigm, but he found the small market that the Nissan Leaf missed.
- NASA was fragile to modern, cheap, off-the-shelf space solutions, and…yet again…Elon Musk was anti-fragile.
- Taxis were fragile to app-based rides.
- Hotels were fragile to app-based rentals.
- Cable was fragile to sticks you put in your TV.
- Hedge funds were fragile to index funds, currently are fragile to copy trading, and I hope to god they break.
- Lastly, some counter-examples, since it is always better to use the via negativa, and assuming you have additive knowledge is dangerous. If you disagree, prove me wrong, found a startup, and make a bajillion dollars by disrupting the big guys who won’t be able to find a market:
- There is nothing disruptive about 5G.
- Solar and wind are fragile and fragilizing.
- What was wrong with WeWork’s business model? Double fragility–fixed contracts with building owners, flexible contracts with customers.
- On a more optimistic note, cool tech can still be sustaining (as opposed to disruptive), like RoboAdvisors or induction stoves or 3D printed shoes.
- Artificial intelligence or blockchain any use you have heard of (but not in any that you don’t know yet).
So, to summarize, if a company is fragile to a new strategy, the best it can do is try to robustify itself, since it has little upside. Many innovations give upside to incumbents at the marginal cost of R&D, and thus sustain them; disruption happens when the incumbents have little to gain from adopting a strategy, but startups have a high exposure to positive impact from possible adoption of a strategy due to the potential growth from small-market, incremental/simplifying opportunities, which is definitionally anti-fragility to the strategy.
Now, I hope you have a tool for judging whether industrial incumbents are fragile. Rather than trying to predict success or failure of any, you should just use Taleb’s heuristic–that will help you sort things into ‘hyped as disruptive’ vs. ‘actually probably disruptive.’ A last thought: if you found this wildly confusing, just remember, disruptive innovations tend to steal the jobs of incumbents. So, if an incumbent (say, a Goldman Sachs/Morgan Stanley veteran writing the definition of “disruptive” for Investopedia) is talking about a banking or trading technology, it is almost certainly not disruptive, since he would hardly tell you how to render him extraneous. You will find out what is disruptive when he makes an apology video while wearing a nice watch and French cuffs.